ArriVent BioPharma, Inc. (NASDAQ:AVBP) Financings

ArriVent BioPharma, Inc.

Financings

RaiseDate
Public offering of common stock and pre-funded warrants
Announced: US$75M · US$19.5 a share · Goldman Sachs & Co. LLC +7
Dealers: Goldman Sachs & Co. LLC (co-lead), Citigroup (co-lead), Guggenheim Securities (co-lead), LifeSci Capital, Oppenheimer & Co., B. Riley Securities, H.C. Wainwright & Co., Jones
Use of proceeds: Support activities for firmonertinib and other pipeline programs, working capital and general corporate purposes
Jul 1, 2025

Read by 6ix AI from the company's releases